bg
M

Macrogenics (MGNX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Macrogenics (MGNX)

MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company dev... Read more

  • USD14.65
  • USD14.93
  • USD14.19
  • USD21.88
  • 0.70%
  • 59M
  • 195.19k
  • 1.39M
  • 911M
  • 4.29
  • 115.10%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.